PROTECTING INTELLECTUAL PROPERTY IN A HIGHLY COLLABORATIVE ENVIRONMENT

No ratings

Presented at CSO50 2017 by

Carolyn Smith

Michael Stanley

Seeking to deliver truly innovative and life-changing drugs, Celgene has created compounds for more than 300 clinical trials at major medical centers. To Celgene, the next most precious thing beyond their employees is the organization’s intellectual property and the information used by employees. Unlike Financial Services or other highly regulated companies, Celgene’s data protection needs are unique since their environment is highly collaborative with new types of information being created continuously. Join us for this session to learn how Celgene has embarked on a long-term data loss prevention journey that methodically addresses the needs of each business unit across the organization. Celgene Protecting Intellectual Property